Keywords: non-pharma, business, hits, tanabe, 3rd-qtr, result, poor
Non-pharma business hits Tanabe's 3rd-qtr
Article | 21 February 2005
As a result of poor performances from non-pharmaceutical operations, Japan's Tanabe reported weak consolidated results for the first nine months ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
